Your browser doesn't support javascript.
loading
A predictive signature for oxaliplatin and 5-fluorouracil based chemotherapy in locally advanced gastric cancer.
Wang, Qinchuan; Liu, Xiyong; Chen, Chen; Chen, Jida; Xu, Beisi; Chen, Lini; Zhou, Jichun; Huang, Yasheng; Chen, Wenjun; Teng, Rongyue; Zhao, Wenhe; Jin, Lidan; Shen, Jun; Shen, Jianguo; Yen, Yun; Wang, Linbo.
Afiliação
  • Wang Q; Department of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Department of Molecular Pharmacology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States of America; Department of Big Data and Health Statistics
  • Liu X; Department of Molecular Pharmacology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States of America.
  • Chen C; Department of Big Data and Health Statistics, School of Public Health, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Chen J; Department of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Xu B; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, United States of America.
  • Chen L; Department of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Zhou J; Department of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Huang Y; Department of Molecular Pharmacology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States of America; Department of Urology, Hangzhou Traditional Chinese Medicine Hospital, Hangzhou, China.
  • Chen W; Department of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Teng R; Department of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Zhao W; Department of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Jin L; Department of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Shen J; Department of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Shen J; Department of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Yen Y; Department of Molecular Pharmacology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States of America; Taipei Medical University, Taipei, Taiwan. Electronic address: yyen@tmu.edu.tw.
  • Wang L; Department of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Electronic address: linbowang@zju.edu.cn.
Transl Oncol ; 14(1): 100901, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33091827
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Oncol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Oncol Ano de publicação: 2021 Tipo de documento: Article